Glenmark Pharmaceuticals
GLENMARK.NS
#2617
Rank
A$8.01 B
Marketcap
$28.39
Share price
-2.94%
Change (1 day)
56.44%
Change (1 year)

Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)

Earnings in 2024 (TTM): A$0.40 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings are A$1.53 Billion. , an increase over its 2023 earnings that were of -A$98.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Glenmark Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 A$0.42 B-529.64%
2023 -A$98.75 Million-129.25%
2022 A$0.33 B-13.93%
2021 A$0.39 B4.71%
2020 A$0.37 B18.76%
2019 A$0.31 B-15.93%
2018 A$0.37 B36.53%
2017 A$0.27 B-31.84%
2016 A$0.40 B66.82%
2015 A$0.24 B8.58%
2014 A$0.22 B-18.39%
2013 A$0.27 B3.66%
2012 A$0.26 B